(h) Clear Market. During the period from the date hereof
through and including the date that is 10 days after the Closing Date, the Company will not, without the prior written consent of the Representatives, offer, sell, contract to sell or otherwise dispose of any debt securities issued or guaranteed by
(i) DTC. The Company will assist the Representatives in arranging for the Securities to be
eligible for clearance and settlement through DTC, Euroclear Bank S.A./N.V. and Clearstream Banking, société anonyme, Luxembourg.
(j) Use of Proceeds. The Company will apply the net proceeds from the sale of the Securities as described in the
Registration Statement, the Time of Sale Information and the Prospectus under the heading Use of Proceeds.
(k) No Stabilization. Neither the Company nor any of its Controlled Entities, has taken or will take, directly
or indirectly, any action designed to or that constituted or which could reasonably be expected to cause or result in any stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Securities.
(l) NDRC Filing. The Company shall file with the NDRC within the applicable time period any requisite
information and documents required under Section 1(3) of the NDRC Notice after the issuance of the Securities (Post-Issuance Filing) and shall notify the Representatives via email within a reasonable time once such
Post-Issuance Filing is completed.
(m) SGX-ST. The Company has
obtained approval-in-principle for the Securities to be listed on the Official List of the Singapore Exchange Security Trading Limited (the SGX-ST), subject to the conditions set forth in the approval-in-principle received from the SGX-ST. The Company will use its
reasonable best efforts to have the Securities admitted for trading, and maintain the listing of the Securities, on the SGX-ST. If the Company is unable to maintain such listing having used its reasonable best
efforts, it being understood that reasonable best efforts does not include the public disclosure of sensitive information that the Company otherwise does not and is not required to publicly disclose, the Company agrees to use its reasonable best
efforts to obtain and maintain a listing of the Securities on a comparable stock exchange to be selected after consultation with the Representatives.
(n) Taxes. The Company agrees to hold the Underwriters harmless against any documentary, stamp or similar
transfer or issue tax, including any interest and penalties, on the issue, sale and delivery to the Underwriters, and the resale by the Underwriters of the Securities in accordance with the terms of this Agreement and on the execution and delivery
of this Agreement and the Indenture which are or may be required to be paid under the laws of the Cayman Islands, the British Virgin Islands, Hong Kong, Singapore, the PRC or any political subdivision or taxing authority thereof or therein.
Moreover, all payments to be made by the Company hereunder will be made without withholding or deduction for or on account of any present or future taxes, duties or governmental charges whatsoever unless the Company is compelled by law to deduct or
withhold such taxes, duties or chargers. In that event, the Company will pay such additional amounts as may be necessary in order that the net amounts received after such withholding or deduction will equal the amounts that would have been received
if no withholding or deduction had been made.
5. Certain Agreements of the Underwriters. Each Underwriter
hereby represents and agrees that:
(a) It has not and will not use, authorize use of, refer to, or participate in
the planning for use of, any free writing prospectus as defined in Rule 405 under the Securities Act (which term includes use of any written information furnished to the Commission by the Company and not incorporated by reference into
the Registration Statement and any press release issued by the Company) other than (i) any Issuer Free Writing Prospectus identified on Annex A as forming part of the Time of Sale Information or prepared pursuant to Section 2(d) or
Section 4(c) above, (ii) any free writing prospectus prepared by such underwriter and approved by the Company in advance in writing or (iii) any free writing prospectus that, solely as a result of use by such Underwriter, would not
trigger an obligation to file such free writing prospectus with the Commission pursuant to Rule 433.